Australija - anglų - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - thiomersal; selenium as sodium selenate; clostridium chauvoei - toxoid; clostridium novyi type b - toxoid; clostridium perfringens type d toxoid; clostridium septicum - toxoid; clostridium tetani - toxoid - parenteral liquid/solution/suspension - thiomersal mercury active 0.13 mg/ml; selenium as sodium selenate mineral-selenium active 0.5 mg/ml; clostridium chauvoei - toxoid vaccine-toxoid active 0.0 p; clostridium novyi type b - toxoid vaccine-toxoid active 3.5 iu/ml; clostridium perfringens type d toxoid vaccine-toxoid active 5.0 iu/ml; clostridium septicum - toxoid vaccine-toxoid active 2.5 iu/ml; clostridium tetani - toxoid vaccine-toxoid active 2.5 iu/ml - immunotherapy - lamb | ovine - black disease | blackleg | enterotoxaemia (pulpy kidney) | malignant oedema | selenium deficiency | tetanus | unthriftiness | white muscle disease | clostridium perfringens type d | ill - thrift | selenium deficiency | selenium responsive ill-thrift | stiff lamb disease | subacute enzootic muscular dys | tetanus vaccination | white muscle disease

Airija - anglų - HPRA (Health Products Regulatory Authority)

intervet ireland limited - clostridium perfringens beta toxoid (strains 554 and 578); clostridium perfringens epsilon toxoid (strain 603); clostridium septicum toxoid (strain 505); clostridium tetani toxoid (strain s1123/91); clostridium novyi toxoid (strain 754); clostridium chauvoei cells and equivalent toxoid of strain 655; clostridium chauvoei cells and equivalent toxoid of strain 656; clostridium chauvoei cells and equivalent toxoid of strain 657; clostridium chauvoei cells and equivalent toxoid of strain 658; clostridium chauvoei cells and equivalent toxoid of strain 1048; formalin pasteurella haemolytica strain a1 (s1006/77); formalin pasteurella haemolytica strain a2 (s1126/92); formalin pasteurella haemolytica strain a6 (s1084/81); formalin pasteurella haemolytica strain a7 (s1078/81); formalin pasteurella haemolytica strain a9 (s994/77); formalin pasteurella trehalosi strain t3 (s1109/84); formalin pasteurella trehalosi strain t4 (s1085/81); formalin pasteurella trehalosi strain t10 (s1075/81); formalin pasteurella trehalosi strain t15 (s1105/84) - suspension for injection - . - clostridium + pasteurella - sheep - immunological - inactivated vaccine

Australija - anglų - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - thiomersal; selenium; clostridium chauvoei - toxoid; clostridium novyi type b - toxoid; clostridium perfringens type d toxoid; clostridium septicum - toxoid; tetanus = clostridium tetani - parenteral liquid/solution/suspension - thiomersal mercury active 0.1 mg/ml; selenium mineral-selenium active 1.0 mg/ml; clostridium chauvoei - toxoid vaccine-toxoid active 0.0 p; clostridium novyi type b - toxoid vaccine-toxoid active 0.0 p; clostridium perfringens type d toxoid vaccine-toxoid active 0.0 p; clostridium septicum - toxoid vaccine-toxoid active 0.0 p; tetanus = clostridium tetani vaccine-toxoid active 0.0 p - immunotherapy - lamb | sheep | ewe | hogget | lamb | ovine | ram | weaner | wether - black disease | blackleg | enterotoxaemia (pulpy kidney) | malignant oedema | tetanus | white muscle disease | clostridium perfringens type d | selenium deficiency | stiff lamb disease | subacute enzootic muscular dys | tetanus vaccination

Australija - anglų - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - clostridium tetani - antitoxin - unknown - clostridium tetani - antitoxin vaccine-toxoid active 0.0 - active constituent

Australija - anglų - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - clostridium chauvoei - toxoid; clostridium novyi type b - toxoid; clostridium perfringens type d toxoid; clostridium septicum - toxoid; clostridium tetani - toxoid; corynebacterium pseudotuberculosis - toxoid; thiomersal - misc. vaccines or anti sera - clostridium chauvoei - toxoid vaccine-toxoid active 0.0 p; clostridium novyi type b - toxoid vaccine-toxoid active 0.0 p; clostridium perfringens type d toxoid vaccine-toxoid active 0.0 p; clostridium septicum - toxoid vaccine-toxoid active 0.0 p; clostridium tetani - toxoid vaccine-toxoid active 0.0 p; corynebacterium pseudotuberculosis - toxoid vaccine-toxoid active 0.0 p; thiomersal mercury other 0.13 g/l - immunotherapy - sheep | ewe | hogget | lamb | ovine | ram | weaner | wether - black disease | blackleg | cheesy gland | enterotoxaemia (pulpy kidney) | malignant oedema | tetanus | clostridium perfringens type d | lymphadenitis | lymphangitis | tetanus vaccination

Australija - anglų - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - vitamin b12; clostridium perfringens type d - antisera/antigen; corynebacterium pseudotuberculosis; clostridium tetani - toxoid; thiomersal - parenteral liquid/solution/suspension - vitamin b12 vitamin-b12 active 2.0 mg/ml; clostridium perfringens type d - antisera/antigen vaccine active 5.0 iu/ml; corynebacterium pseudotuberculosis vaccine active 1.0 iu/ml; clostridium tetani - toxoid vaccine-toxoid active 2.5 iu/ml; thiomersal mercury other 0.13 mg/ml - immunotherapy

Australija - anglų - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - clostridium tetani uf toxoid; thiomersal - misc. vaccines or anti sera - clostridium tetani uf toxoid vaccine-toxoid active 0.0 p; thiomersal mercury other 0.1 mg/ml - immunotherapy - cattle | dog | goat | horse | pigs | sheep | beef | billy | bitch | boar | bos indicus | bos taurus | bovine | buck | buffalo | - tetanus | tetanus vaccination

Naujoji Zelandija - anglų - Ministry for Primary Industries

elanco new zealand - sodium selenate; clostridium perfringens type d toxoid; clostridium chauvoei toxoid/cells; clostridium tetani toxoid; vitamin b12; clostridium septicum toxoid; clostridium novyi type b toxoid/cells; clostridium sordellii toxoid - sodium selenate 5 g/litre; clostridium perfringens type d toxoid 0 vaccine; clostridium chauvoei toxoid/cells 0 vaccine; clostridium tetani toxoid 0 vaccine; vitamin b12 0.65 g/litre; clostridium septicum toxoid 0 vaccine; clostridium novyi type b toxoid/cells 0 vaccine; clostridium sordellii toxoid 0 vaccine - vaccine

Naujoji Zelandija - anglų - Ministry for Primary Industries

zoetis new zealand limited - clostridium chauvoei toxoid/cells; sodium selenate; clostridium novyi type b toxoid/cells; clostridium perfringens type d toxoid; clostridium septicum toxoid; clostridium tetani toxoid - clostridium chauvoei toxoid/cells 0 vaccine; sodium selenate 12 g/litre; clostridium novyi type b toxoid/cells 0 vaccine; clostridium perfringens type d toxoid 0 vaccine; clostridium septicum toxoid 0 vaccine; clostridium tetani toxoid 0 vaccine - vaccine

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

a-s medication solutions - clostridium tetani toxoid antigen (formaldehyde inactivated) (unii: k3w1n8yp13) (clostridium tetani toxoid antigen (formaldehyde inactivated) - unii:k3w1n8yp13), corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (unii: irh51qn26h) (corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) - unii:irh51qn26h), bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) (unii: qsn5xo8zsu) (bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde in - boostrix is indicated for:     •    active booster immunization against tetanus, diphtheria, and pertussis in individuals aged 10 years and older,     •    immunization during the third trimester of pregnancy to prevent pertussis in infants younger than 2 months of age. do not administer boostrix to individuals with a known history of severe allergic reaction (e.g., anaphylaxis) to any component of boostrix or after a previous dose of any tetanus toxoid-, diphtheria toxoid-, or pertussis antigen-containing vaccine [see description (11)] . encephalopathy within 7 days of administration of a previous dose of a pertussis antigen-containing vaccine that is not attributable to another identifiable cause is a contraindication to administration of any pertussis antigen-containing vaccine, including boostrix. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to boostrix during pregnancy. healthcare providers are encouraged to register women by calling